BRT provides bioanalytical and cell-based approaches to support immunogenicity assessment, immune response characterization, and customized assay development across preclinical research programs.
BRT provides immunogenicity testing and assay development to evaluate immune responses to therapeutic and vaccine candidates.
BRT supports the development, validation, and implementation of immunoassays for customized preclinical research programs.
BRT offers cell-based assays to evaluate functional immune responses and support customized bioanalytical and immunogenicity programs.
BRT offers bioanalytical approaches to evaluate cytokine, complement, and other biomarker responses within customized preclinical research programs.
BRT utilizes a range of assay platforms and technologies to support customized bioanalytical, cell-based, and immunogenicity programs.
We work with clients to develop customized bioanalytical, cell-based, and immunogenicity assays based on specific research objectives, test articles, assay systems, and endpoints.
